Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Frontiers in Cardiovascular Medicine
|
September 24, 2024
One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy
Daniel Seung Kim, Emily L Chu, Emily E Keamy-Minor, et al.
Circulation. Genomic and Precision Medicine
|
June 7, 2022
Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy
Hannah N De Jong, Frederick E Dewey, Pablo Cordero, et al.
Circulation. Heart Failure
|
March 16, 2019
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy
Victoria N Parikh, Colleen Caleshu, Chloe Reuter, et al.
Journal of the American College of Cardiology
|
July 8, 2026
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry
Constantin-Cristian Topriceanu, Iswaree Devi Balakrishnan, Christoffer Rasmus Vissing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 25, 2025
Mapping the Functional Landscape of <i>KCNQ1</i> to Define Ion Channel Mechanisms and Arrhythmia Risk
M Lorena Harvey, Ellen Osborn, Megan C Lancaster, et al.
The Journal of Clinical Investigation
|
August 23, 2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Thomas Bertero, William M Oldham, Katherine A Cottrill, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 13, 2021
The genetic architecture of Plakophilin 2 cardiomyopathy
Annika M Dries, Anna Kirillova, Chloe M Reuter, et al.
Nature Communications
|
June 26, 2019
Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure
Pablo Cordero, Victoria N Parikh, Elizabeth T Chin, et al.
Circulation
|
December 5, 2024
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy
Joshua K Meisner, Aaron Renberg, Eric D Smith, et al.
European Heart Journal
|
August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
Douglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Frontiers in Cardiovascular Medicine
|
September 24, 2024
One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy
Daniel Seung Kim, Emily L Chu, Emily E Keamy-Minor, et al.
Circulation. Genomic and Precision Medicine
|
June 7, 2022
Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy
Hannah N De Jong, Frederick E Dewey, Pablo Cordero, et al.
Circulation. Heart Failure
|
March 16, 2019
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy
Victoria N Parikh, Colleen Caleshu, Chloe Reuter, et al.
Journal of the American College of Cardiology
|
July 8, 2026
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry
Constantin-Cristian Topriceanu, Iswaree Devi Balakrishnan, Christoffer Rasmus Vissing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 25, 2025
Mapping the Functional Landscape of <i>KCNQ1</i> to Define Ion Channel Mechanisms and Arrhythmia Risk
M Lorena Harvey, Ellen Osborn, Megan C Lancaster, et al.
The Journal of Clinical Investigation
|
August 23, 2016
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Thomas Bertero, William M Oldham, Katherine A Cottrill, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 13, 2021
The genetic architecture of Plakophilin 2 cardiomyopathy
Annika M Dries, Anna Kirillova, Chloe M Reuter, et al.
Nature Communications
|
June 26, 2019
Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure
Pablo Cordero, Victoria N Parikh, Elizabeth T Chin, et al.
Circulation
|
December 5, 2024
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy
Joshua K Meisner, Aaron Renberg, Eric D Smith, et al.
European Heart Journal
|
August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure
Douglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
Page
of 7